• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Endophthalmitis (1835); Iritis (1940); Uveitis (2122); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Event Description
A case report from the journal of vitreoretinal diseases was received in regard to "culture-negative c acnes endophthalmitis following implantation of a phakic implantable collamer lens".The case report was about a 34-year-old woman who presented with chronic unilateral iritis, with precipitates 5 months after bilateral implantable collamer (icl) implantation in the left eye (os).Treatment with topical prednisolone acetate was initially successful but the iritis recurred.The patient was referred to a uveitis specialist at eight months postop, and tests for uveitis had negative findings.Ultrasound biomicroscopy showed possible chaffing of the iris by the icl.At 10 months after the initial surgery, the icl was removed.Patient continued to develop worsening floaters and va.One year after icl placement, patient had 2+ vitritis with small deposits on posterior surface of natural lens.A diagnostic vitrectomy was performed that was culture negative.Trial of oral prednisone resulted in only transient improvement of uveitis.A second vitrectomy combined with lensectomy was performed.Cultures had negative findings, but bacterial pcr testing was positive for c acnes.Treatment with intravitreal vancomycin and ceftazidime was administered.At 3 months follow-up, patient had complete resolution of ocular inflammation and treatments discontinued.At one-year follow-up patient's vision was 20/20 with correction for aphakia.Additional information has been requested but none has been forthcoming.
 
Manufacturer Narrative
Weight: unk.Ethnicity: unk.Race: unk.Date of event: unk.Expiration date unk.Implant date: unk.Explant date: unk.Device manufacture date: unk.Health impact- clinical code: (b)(4) precipitates; iris chaffing.Health effect impact code: (b)(4) topical prednisolone acetate.Claim # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Type of Device
PHAKIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
joselene enriquez
1911 walker avenue
monrovia, CA 91016
MDR Report Key14365002
MDR Text Key291488987
Report Number2023826-2022-01477
Device Sequence Number1
Product Code MTA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/11/2022
Initial Date FDA Received05/11/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age34 YR
Patient SexFemale
-
-